Bert Schepens

5.0k citations

65 papers · 3.6k · h-index 34

Impact in

Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- COVID-19 Clinical Research Studies
Epidemiology top 2%
- Influenza Virus Research Studies
- Respiratory viral infections research

Papers in

Epidemiology 42
- Influenza Virus Research Studies 27
- Respiratory viral infections research 22
Immunology 30
- Immune Cell Function and Interaction 9
- Immune Response and Inflammation 9
- Immunotherapy and Immune Responses 8

Co-authors: Xavier Saelens (55 shared papers)Walter C. Fiers (15 shared papers)Kenny Roose (18 shared papers)Dorien De Vlieger (6 shared papers)Michael Schotsaert (13 shared papers)Jason S. McLellan (5 shared papers)Lorena Itatí Ibañez (8 shared papers)Marina De Filette (4 shared papers)
Journals: Journal of Virology (8 papers)PLoS ONE (3 papers)The Journal of Infectious Diseases (3 papers)Antiviral Research (3 papers)Nature Communications (3 papers)
Partner nations: Belgium United States Germany

In The Last Decade

Bert Schepens

65 papers receiving 3.5k citations

Peers

Replace Kenny Roose with:

Kenny Roose Belgium

Chih‐Jen Wei United States

Raffael Nachbagauer United States

Pavlo Gilchuk United States

Darrick Carter United States

Ricardo Carrion Jr United States

Shirin Strohmeier United States

Wenli Yu United States

Yanling Wu China

Bin Zhou United States

Bert Schepens relative to Kenny Roose Belgium Kenny Roose's profile →

Citations per field

00.5×1.6×

Kenny Roose · 1×

×1.2 1k/1k

ID

×1.5 1k/955

EPIDE

×1.1 923/846

IMMUN

×1.6 911/586

RNMI

×1.3 208/166

ASZ

Citations per year

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

'26

Countries citing papers authored by Bert Schepens

Since Specialization

Citations

This map shows the geographic impact of Bert Schepens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Schepens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Schepens more than expected).

Fields of papers citing papers by Bert Schepens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bert Schepens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Schepens. The network helps show where Bert Schepens may publish in the future.

Co-authors

The 25 scholars most cited alongside Bert Schepens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bert Schepens Line = papers co-authored together Bert Schepens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies Cell ·Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Gretel M. Torres, Nianshuang Wang, Wander Van Breedam, Kenny Roose, Loes van Schie	2020	486
2	M2e-based universal influenza A vaccine Vaccine ·Walter C. Fiers, Marina De Filette, Karim El Bakkouri, Bert Schepens, Kenny Roose, Michael Schotsaert, Ashley J. Birkett, Xavier Saelens	2009	300
3	STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters Nature Communications ·Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein, Rong Li, Valentijn Vergote, Laura Seldeslachts, Johan Van Weyenbergh, Carolien De Keyzer	2020	212
4	Interferon-Inducible Protein Mx1 Inhibits Influenza Virus by Interfering with Functional Viral Ribonucleoprotein Complex Assembly Journal of Virology ·Judith Verhelst, Eef Parthoens, Bert Schepens, Walter C. Fiers, Xavier Saelens	2012	178
5	Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules PLoS ONE ·Anna Hultberg, Nigel James Temperton, Valérie Rosseels, Mireille Koenders, María González-Pajuelo, Bert Schepens, Lorena Itatí Ibañez, Peter Vanlandschoot	2011	160
6	Nanobodies®: New ammunition to battle viruses Antiviral Research ·Peter Vanlandschoot, Catelijne Stortelers, Els Beirnaert, Lorena Itatí Ibañez, Bert Schepens, Erik Depla, Xavier Saelens	2011	123
7	Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies Cell ·Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Gretel M. Torres, Nianshuang Wang, Wander Van Breedam, Kenny Roose, Loes van Schie	2020	117
8	M2-based influenza vaccines: recent advances and clinical potential Expert Review of Vaccines ·Annasaheb B. Kolpe, Bert Schepens, Walter C. Fiers, Xavier Saelens	2016	99
9	Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection The Journal of Infectious Diseases ·Lorena Itatí Ibañez, Marina De Filette, Anna Hultberg, Theo C. Verrips, Nigel James Temperton, Robin A. Weiss, Wesley Vandevelde, Bert Schepens	2011	95
10	A role for hnRNP C1/C2 and Unr in internal initiation of translation during mitosis The EMBO Journal ·Bert Schepens, Sandrine A. Tinton, Yanik Bruynooghe, Eef Parthoens, Mira Haegman, Rudi Beyaert, Sigrid Cornelis	2006	87
11	Single-Domain Antibodies and Their Formatting to Combat Viral Infections Antibodies ·Dorien De Vlieger, Marlies Ballegeer, Iebe Rossey, Bert Schepens, Xavier Saelens	2018	82
12	Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state Nature Communications ·Iebe Rossey, Morgan S. A. Gilman, Stephanie C. Kabeche, Koen Sedeyn, Daniel Wrapp, Masaru Kanekiyo, Man Chen, Vicente Más	2017	75
13	The polypyrimidine tract-binding protein stimulates HIF-1 IRES-mediated translation during hypoxia Nucleic Acids Research ·Bert Schepens	2005	73
14	Single-Domain Antibodies Targeting Neuraminidase Protect against an H5N1 Influenza Virus Challenge Journal of Virology ·Francisco Miguel Lopez Cardoso, Lorena Itatí Ibañez, Silvie Van den Hoecke, Sarah De Baets, Anouk Smet, Kenny Roose, Bert Schepens, Francis J. Descamps	2014	73
15	Regulation of the cell-cycle-dependent internal ribosome entry site of the PITSLRE protein kinase: roles of Unr (upstream of N-ras) protein and phosphorylated translation initiation factor eIF-2α Biochemical Journal ·Sandrine A. Tinton, Bert Schepens, Yanik Bruynooghe, Rudi Beyaert, Sigrid Cornelis	2004	72
16	Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies Journal of Virology ·Silvie Van den Hoecke, Katrin Ehrhardt, Annasaheb B. Kolpe, Karim El Bakkouri, Lei Deng, Hendrik Grootaert, Steve Schoonooghe, Anouk Smet	2017	67
17	Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses PLoS Pathogens ·Koen Sedeyn, Bert Schepens, Xavier Saelens	2019	67
18	Hepatitis B core–based virus–like particles to present heterologous epitopes Expert Review of Vaccines ·Kenny Roose, Sarah De Baets, Bert Schepens, Xavier Saelens	2013	60
19	Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages Molecular & Cellular Proteomics ·Sandra Söderholm, Denis E. Kainov, Tiina Öhman, Oxana V. Denisova, Bert Schepens, Evgeny Kulesskiy, Susumu Y. Imanishi, Garry L. Corthals	2016	57
20	Clinical Potential of Prefusion RSV F-specific Antibodies Trends in Microbiology ·Iebe Rossey, Jason S. McLellan, Xavier Saelens, Bert Schepens	2017	54

About Bert Schepens

Bert Schepens is a scholar working on Epidemiology, Immunology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases and Molecular Biology, having authored 65 papers that have together received 3.6k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (27 papers), Respiratory viral infections research (22 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), Viral gastroenteritis research and epidemiology (11 papers), Immune Cell Function and Interaction (9 papers), Immune Response and Inflammation (9 papers), Immunotherapy and Immune Responses (8 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Epidemiology (1.5k citations), Immunology (923 citations), Radiology, Nuclear Medicine and Imaging (911 citations) and Animal Science and Zoology (208 citations). Bert Schepens has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Xavier Saelens, Walter C. Fiers, Kenny Roose, Dorien De Vlieger, Michael Schotsaert, Jason S. McLellan, Lorena Itatí Ibañez, Marina De Filette, Nico Callewaert and Koen Sedeyn. Their work appears in journals such as Journal of Virology, PLoS ONE, The Journal of Infectious Diseases, Antiviral Research and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Bert Schepens

Impact in

Papers in i

In The Last Decade

Bert Schepens

Peers

Countries citing papers authored by Bert Schepens

Fields of papers citing papers by Bert Schepens

All Works

About Bert Schepens

Explore authors with similar magnitude of impact

Papers in